Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Adlai Nortye Biopharma Co., Ltd.

Clinical trials sponsored by Adlai Nortye Biopharma Co., Ltd., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New cancer pill AN4005 enters first human tests Results expected Nov 2026 (estimated)
New drug AN8025 tested in patients with advanced cancers Results expected Jul 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 3 Not yet recruiting 1 Completed 1

New combo shows promise in Tough-to-Treat head and neck cancer

Disease control Completed

This study tested whether adding the drug buparlisib to standard chemotherapy (paclitaxel) helps people with advanced head and neck cancer live longer. About 487 adults whose cancer had returned or spread and who had already tried other treatments took part. The goal was to see i…

Phase 3 • Sponsor: Adlai Nortye Biopharma Co., Ltd. • Aim: Disease control

Last updated Jun 27, 2026 07:57 UTC